{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:25:44Z","timestamp":1777879544666,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Haiyan Founding project of Harbin Medical University Cancer Hospital","award":["NO. JJMS 2022-14"],"award-info":[{"award-number":["NO. JJMS 2022-14"]}]},{"name":"Innovation funding for technology of Harbin Medical University Cancer Hospital","award":["NO. 2023-1-S-13"],"award-info":[{"award-number":["NO. 2023-1-S-13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10495-025-02206-w","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T07:38:39Z","timestamp":1774597119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of POLE2\/GINS1-mediated AKT\/mTOR pathway in RCC autophagy, proliferation, and metastasis: evidences from bioinformatic, clinical, and experimental data"],"prefix":"10.1007","volume":"31","author":[{"given":"Yajuan","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songlin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lichen","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"2206_CR1","volume":"7","author":"J Deng","year":"2024","unstructured":"Deng J, Tu S, Li L, Li G, Zhang Y (2024) Diagnostic, predictive and prognostic molecular biomarkers in clear cell renal cell carcinoma: a retrospective study. Cancer Rep (Hoboken, NJ) 7:e2116","journal-title":"Cancer Rep (Hoboken, NJ)"},{"key":"2206_CR2","doi-asserted-by":"publisher","first-page":"153303382412754","DOI":"10.1177\/15330338241275403","volume":"23","author":"S Boussios","year":"2024","unstructured":"Boussios S, Ovsepian SV (2024) Exosomes in renal cell cancer: diagnostic and therapeutic nanovehicles. Technol Cancer Res Treat 23:15330338241275404","journal-title":"Technol Cancer Res Treat"},{"key":"2206_CR3","first-page":"11921","volume":"31","author":"AS Iskandar","year":"2024","unstructured":"Iskandar AS, Zarrabi KK, Tester WJ (2024) Renal cell carcinoma: entering the age of biomarkers. Can J Urol 31:11921\u201311930","journal-title":"Can J Urol"},{"key":"2206_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16101856","author":"F Sanguedolce","year":"2024","unstructured":"Sanguedolce F, Mazzucchelli R, Falagario UG et al (2024) Diagnostic biomarkers in renal cell tumors according to the latest WHO classification: a focus on selected new entities. Cancers. https:\/\/doi.org\/10.3390\/cancers16101856","journal-title":"Cancers"},{"key":"2206_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/10668969241256111","author":"BG Nezami","year":"2024","unstructured":"Nezami BG, MacLennan GT (2024) Clear cell renal cell carcinoma: a comprehensive review of its histopathology, genetics, and differential diagnosis. Int J Surg Pathol. https:\/\/doi.org\/10.1177\/10668969241256111","journal-title":"Int J Surg Pathol"},{"key":"2206_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0140-6736(24)00917-6","volume":"404","author":"M Young","year":"2024","unstructured":"Young M, Jackson-Spence F, Beltran L et al (2024) Renal cell carcinoma. Lancet 404:476\u2013491","journal-title":"Lancet"},{"key":"2206_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12051111","author":"C Baston","year":"2024","unstructured":"Baston C, Parosanu AI, Stanciu IM, Nitipir C (2024) Metastatic kidney cancer: does the location of the metastases matter? Moving towards personalized therapy for metastatic renal cell carcinoma. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12051111","journal-title":"Biomedicines"},{"key":"2206_CR8","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.3390\/curroncol31080359","volume":"31","author":"A Tejura","year":"2024","unstructured":"Tejura A, Fernandes R, Hubay S, Ernst MS, Valdes M, Batra A (2024) Contemporary management of renal cell carcinoma: a review for general practitioners in oncology. Curr Oncol (Toronto, Ont) 31:4795\u20134817","journal-title":"Curr Oncol (Toronto, Ont)"},{"key":"2206_CR9","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2024.0147","author":"P Ivanyi","year":"2024","unstructured":"Ivanyi P, Fr\u00f6hlich T, Gr\u00fcnwald V, Zsch\u00e4bitz S, Bedke J, Doehn C (2024) The treatment of metastatic renal cell carcinoma. Dtsch Arztebl Int. https:\/\/doi.org\/10.3238\/arztebl.m2024.0147","journal-title":"Dtsch Arztebl Int"},{"key":"2206_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.dnarep.2019.02.007","volume":"76","author":"VS Park","year":"2019","unstructured":"Park VS, Pursell ZF (2019) POLE proofreading defects: contributions to mutagenesis and cancer. DNA Repair 76:50\u201359","journal-title":"DNA Repair"},{"key":"2206_CR11","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s00432-018-2746-x","volume":"144","author":"M Guenther","year":"2018","unstructured":"Guenther M, Veninga V, Kumbrink J et al (2018) POLE gene hotspot mutations in advanced pancreatic cancer. J Cancer Res Clin Oncol 144:2161\u20132166","journal-title":"J Cancer Res Clin Oncol"},{"key":"2206_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41419-021-04498-7","volume":"13","author":"P Zhang","year":"2022","unstructured":"Zhang P, Chen X, Zhang L et al (2022) POLE2 facilitates the malignant phenotypes of glioblastoma through promoting AURKA-mediated stabilization of FOXM1. Cell Death Dis 13:61","journal-title":"Cell Death Dis"},{"key":"2206_CR13","doi-asserted-by":"publisher","first-page":"2392339","DOI":"10.1080\/15384047.2024.2392339","volume":"25","author":"W Jian","year":"2024","unstructured":"Jian W, Zhang L (2024) POLE2 silencing inhibits the progression of colorectal carcinoma cells via wnt signaling axis. Cancer Biol Ther 25:2392339","journal-title":"Cancer Biol Ther"},{"key":"2206_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41420-024-01875-x","volume":"10","author":"B Wang","year":"2024","unstructured":"Wang B, Hu H, Wang X et al (2024) POLE2 promotes osteosarcoma progression by enhancing the stability of CD44. Cell Death Discov 10:177","journal-title":"Cell Death Discov"},{"key":"2206_CR15","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.7150\/jca.93023","volume":"15","author":"L Yu","year":"2024","unstructured":"Yu L, Lin N, Ye Y et al (2024) Prognostic and chemotherapeutic response prediction by proliferation essential gene signature: investigating POLE2 in bladder cancer progression and cisplatin resistance. J Cancer 15:1734\u20131749","journal-title":"J Cancer"},{"key":"2206_CR16","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.2174\/0113862073273633231113060429","volume":"27","author":"D Jiang","year":"2024","unstructured":"Jiang D, Zhang H, Yin B, He M, Lu X, He C (2024) The prognostic hub gene POLE2 promotes BLCA cell growth via the PI3K\/AKT signaling pathway. Combin Chem High Throughput Screen 27:1984\u20131998","journal-title":"Combin Chem High Throughput Screen"},{"key":"2206_CR17","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1007\/s11596-023-2813-7","volume":"43","author":"MY Sun","year":"2023","unstructured":"Sun MY, Wang L, Shen ZY (2023) POLE2 regulates apoptosis of oral squamous cell carcinoma cells through the PI3K\/AKT signaling pathway. Curr Med Sci 43:1162\u20131172","journal-title":"Curr Med Sci"},{"key":"2206_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.622344","volume":"9","author":"C Zhang","year":"2021","unstructured":"Zhang C, Shen Y, Gao L et al (2021) Targeting POLE2 creates a novel vulnerability in renal cell carcinoma via modulating Stanniocalcin 1. Front Cell Dev Biol 9:622344","journal-title":"Front Cell Dev Biol"},{"key":"2206_CR19","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M et al (2020) Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol 38:675\u2013678","journal-title":"Nat Biotechnol"},{"key":"2206_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P (2015) The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst 1:417\u2013425","journal-title":"Cell Syst"},{"key":"2206_CR21","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jgg.2019.11.010","volume":"46","author":"M Zhao","year":"2019","unstructured":"Zhao M, Liu Y, Zheng C, Qu H (2019) dbEMT 2.0: an updated database for epithelial-mesenchymal transition genes with experimentally verified information and precalculated regulation information for cancer metastasis. J Genet Genomics 46:595\u2013597","journal-title":"J Genet Genomics"},{"key":"2206_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12935-020-01477-4","volume":"20","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Chen G, Song Y, Chen Z, Chen X (2020) POLE2 knockdown reduce tumorigenesis in esophageal squamous cells. Cancer Cell Int 20:388","journal-title":"Cancer Cell Int"},{"key":"2206_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11010-023-04738-8","volume":"479","author":"Z Lv","year":"2024","unstructured":"Lv Z, Wu X, Lu P et al (2024) POLE2 knockdown suppresses lymphoma progression via downregulating Wnt\/\u03b2-catenin signaling pathway. Mol Cell Biochem 479:487\u2013497","journal-title":"Mol Cell Biochem"},{"key":"2206_CR24","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.921430","volume":"26","author":"Z Wu","year":"2020","unstructured":"Wu Z, Wang YM, Dai Y, Chen LA (2020) POLE2 serves as a prognostic biomarker and is associated with immune infiltration in squamous cell lung cancer. Med Sci Monit 26:e921430","journal-title":"Med Sci Monit"},{"key":"2206_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/iub.2900","author":"V Pourbarkhordar","year":"2024","unstructured":"Pourbarkhordar V, Rahmani S, Roohbakhsh A, Hayes AW, Karimi G (2024) Melatonin effect on breast and ovarian cancers by targeting the PI3K\/Akt\/mTOR pathway. IUBMB Life. https:\/\/doi.org\/10.1002\/iub.2900","journal-title":"IUBMB Life"},{"key":"2206_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111218","volume":"402","author":"FZ Mokhfi","year":"2024","unstructured":"Mokhfi FZ, Al Amin M, Zehravi M et al (2024) Alkaloid-based modulators of the PI3K\/Akt\/mTOR pathway for cancer therapy: understandings from pharmacological point of view. Chem Biol Interact 402:111218","journal-title":"Chem Biol Interact"},{"key":"2206_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12935-024-03454-7","volume":"24","author":"S Zhan","year":"2024","unstructured":"Zhan S, Bai X, Zhao Y et al (2024) TGFBI promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through PI3K\/AKT\/mTOR\/HIF-1\u03b1 pathway. Cancer Cell Int 24:265","journal-title":"Cancer Cell Int"},{"key":"2206_CR28","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17555","volume":"12","author":"T Qin","year":"2024","unstructured":"Qin T, Huang M, Wei W et al (2024) PLAUR facilitates the progression of clear cell renal cell carcinoma by activating the PI3K\/AKT\/mTOR signaling pathway. PeerJ 12:e17555","journal-title":"PeerJ"},{"key":"2206_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s12967-024-05273-w","volume":"22","author":"D Zheng","year":"2024","unstructured":"Zheng D, Ning J, Deng H, Ruan Y, Cheng F (2024) TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT\/mTOR signaling. J Transl Med 22:481","journal-title":"J Transl Med"},{"key":"2206_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16142598","author":"F Petrelli","year":"2024","unstructured":"Petrelli F, Vavassori I, Rossitto M, Dottorini L (2024) Management of metastatic renal cell carcinoma following first-line immune checkpoint therapy failure: a systematic review. Cancers. https:\/\/doi.org\/10.3390\/cancers16142598","journal-title":"Cancers"},{"key":"2206_CR31","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/s41467-024-45946-0","volume":"15","author":"M Day","year":"2024","unstructured":"Day M, Tetik B, Parlak M et al (2024) TopBP1 utilises a bipartite GINS binding mode to support genome replication. Nat Commun 15:1797","journal-title":"Nat Commun"},{"key":"2206_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114125","volume":"440","author":"Q Fu","year":"2024","unstructured":"Fu Q, Zheng H, Wang X et al (2024) GINS1 promotes the initiation and progression of bladder cancer by activating the AKT\/mTOR\/c-Myc signaling pathway. Exp Cell Res 440:114125","journal-title":"Exp Cell Res"},{"key":"2206_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051185","author":"TM Jones","year":"2020","unstructured":"Jones TM, Carew JS, Nawrocki ST (2020) Therapeutic targeting of autophagy for renal cell carcinoma therapy. Cancers. https:\/\/doi.org\/10.3390\/cancers12051185","journal-title":"Cancers"},{"key":"2206_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/PPO.0000000000000374","volume":"25","author":"KL Russell","year":"2019","unstructured":"Russell KL, Gorgulho CM, Allen A et al (2019) Inhibiting autophagy in renal cell cancer and the associated tumor endothelium. Cancer J (Sudbury, Mass) 25:165\u2013177","journal-title":"Cancer J (Sudbury, Mass)"},{"key":"2206_CR35","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.7150\/jca.29285","volume":"10","author":"Q Cao","year":"2019","unstructured":"Cao Q, Bai P (2019) Role of autophagy in renal cancer. J Cancer 10:2501\u20132509","journal-title":"J Cancer"},{"key":"2206_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/tox.23658","volume":"38","author":"F Wu","year":"2023","unstructured":"Wu F, Xie X, Li G et al (2023) AKG induces cell apoptosis by inducing reactive oxygen species-mediated endoplasmic reticulum stress and by suppressing PI3K\/AKT\/mTOR-mediated autophagy in renal cell carcinoma. Environ Toxicol 38:17\u201327","journal-title":"Environ Toxicol"},{"key":"2206_CR37","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1080\/21655979.2021.1960765","volume":"12","author":"X Gong","year":"2021","unstructured":"Gong X, Jiang L, Li W, Liang Q, Li Z (2021) Curcumin induces apoptosis and autophagy inhuman renal cell carcinoma cells via Akt\/mTOR suppression. Bioengineered 12:5017\u20135027","journal-title":"Bioengineered"},{"key":"2206_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051380","author":"R Hua","year":"2018","unstructured":"Hua R, Han S, Zhang N, Dai Q, Liu T, Li J (2018) cPKC\u03b3-modulated sequential reactivation of mTOR inhibited autophagic flux in neurons exposed to oxygen glucose deprivation\/reperfusion. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19051380","journal-title":"Int J Mol Sci"},{"key":"2206_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00172-19","author":"B Zhang","year":"2019","unstructured":"Zhang B, Song Y, Sun S et al (2019) Human Papillomavirus 11 early protein E6 activates autophagy by repressing AKT\/mTOR and Erk\/mTOR. J Virol. https:\/\/doi.org\/10.1128\/JVI.00172-19","journal-title":"J Virol"},{"key":"2206_CR40","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401480R","volume":"38","author":"Y Liu","year":"2024","unstructured":"Liu Y, Chen S, Guo K et al (2024) Osteoblast-derived exosomal miR-140-3p targets ACER2 and increases the progression of prostate cancer via the AKT\/mTOR pathway-mediated inhibition of autophagy. FASEB J 38:e70206","journal-title":"FASEB J"},{"key":"2206_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2024.104909","volume":"138","author":"T \u010cugura","year":"2024","unstructured":"\u010cugura T, Bo\u0161tjan\u010di\u010d E, Uhan S, Hauptman N, Jeruc J (2024) Epithelial-mesenchymal transition associated markers in sarcomatoid transformation of clear cell renal cell carcinoma. Exp Mol Pathol 138:104909","journal-title":"Exp Mol Pathol"},{"key":"2206_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01789-2","volume":"22","author":"W Zhu","year":"2024","unstructured":"Zhu W, Wu C, Liu Z, Zhao S, Huang J (2024) OTU deubiquitinase, ubiquitin aldehyde binding 2 (OTUB2) modulates the stemness feature, chemoresistance, and epithelial-mesenchymal transition of colon cancer via regulating GINS complex subunit 1 (GINS1) expression. Cell Commun Signal 22:420","journal-title":"Cell Commun Signal"},{"key":"2206_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31237","volume":"239","author":"J Liang","year":"2024","unstructured":"Liang J, Yao N, Deng B et al (2024) GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via \u03b2-catenin signaling in hepatocellular carcinoma. J Cell Physiol 239:e31237","journal-title":"J Cell Physiol"},{"key":"2206_CR44","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12935-024-03485-0","volume":"24","author":"Z Li","year":"2024","unstructured":"Li Z, Zhao Q, Liu X et al (2024) Capsaicin combined with cisplatin inhibits TGF-\u03b21-induced EMT and TSCC cells migration via the Claudin-1\/PI3K\/AKT\/mTOR signaling pathway. Cancer Cell Int 24:300","journal-title":"Cancer Cell Int"},{"key":"2206_CR45","doi-asserted-by":"publisher","first-page":"507","DOI":"10.7150\/ijbs.30575","volume":"15","author":"H Feng","year":"2019","unstructured":"Feng H, Zhao X, Guo Q et al (2019) Autophagy resists EMT process to maintain retinal pigment epithelium homeostasis. Int J Biol Sci 15:507\u2013521","journal-title":"Int J Biol Sci"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02206-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-025-02206-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02206-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:46:40Z","timestamp":1777592800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-025-02206-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2206"],"URL":"https:\/\/doi.org\/10.1007\/s10495-025-02206-w","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For clinical samples, written informed consents were obtained, and the protocol was approved by the Ethical Committee of Harbin Medical University Cancer Hospital (No.KY2023-34). Animal experiments are conducted in accordance with ARRIVE guideline and approved by Experimental Animal Ethics Committee of Yangzhou University (No.202406026).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"112"}}